(Q37871561)

24 August 2017

1 reference

title

Adverse effects of concentrated green tea extracts (English)

1 reference

24 August 2017

0 references

Axel H Schönthal

1

1 reference

24 August 2017

publication date

29 April 2011

1 reference

Molecular Nutrition and Food Research

24 August 2017

published in

1 reference

24 August 2017

volume

55

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

874-885

1 reference

Green tea (Camellia sinensis) catechins and vascular function.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Efficacy of green tea in the prevention of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Beneficial effects of green tea--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Beneficial effects of green tea: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Anti-obesity effects of green tea: from bedside to bench.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

The effects of green tea on weight loss and weight maintenance: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

A green tea extract high in catechins reduces body fat and cardiovascular risks in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Green tea catechins, caffeine and body-weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Herbal remedies in the United States: potential adverse interactions with anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Use of alternative medicine by women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Herb and supplement use in the US adult population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Medicinal benefits of green tea: part II. review of anticancer properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Medicinal benefits of green tea: Part I. Review of noncancer health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Potential health benefits of green tea (Camellia sinensis): a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Pesticide residue level in tea ecosystems of Hill and Dooars regions of West Bengal, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Factors affecting the levels of tea polyphenols and caffeine in tea leaves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Total phenol, catechin, and caffeine contents of teas commonly consumed in the United kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Factors affecting the caffeine and polyphenol contents of black and green tea infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effect of dietary Polyphenon E and EGCG on lung tumorigenesis in A/J Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Cancer-preventive effects of drinking green tea among a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

A single ascending dose study of epigallocatechin gallate in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Acute liver failure induced by green tea extracts: case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Hepatotoxicity from green tea: a review of the literature and two unpublished cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Safety of green tea extracts : a systematic review by the US Pharmacopeia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Green tea with a high catechin content suppresses inflammatory cytokine expression in the galactosamine-injured rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Green tea extract protects against early alcohol-induced liver injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Fourteen-Week Toxicity Study of Green Tea Extract in Rats and Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Green tea consumption and liver disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Systematic overview of warfarin and its drug and food interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Herb-drug interactions: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Herbal modulation of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

(-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Reversal of cancer multidrug resistance by green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

In vivo reversal of doxorubicin resistance by (-)-epigallocatechin gallate in a solid human carcinoma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Role of P-glycoprotein in drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Food-drug interaction of (-)-epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Glucuronides of tea catechins: enzymology of biosynthesis and biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Glucuronide transport across the endoplasmic reticulum membrane is inhibited by epigallocatechin gallate and other green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Pharmacogenetics of irinotecan disposition and toxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Food-drug interactions via human cytochrome P450 3A (CYP3A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Dietary Effects on Drug Metabolism and Transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Cancer prevention with natural compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Green tea in chemoprevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effects of Chinese, Japanese and Western tea on hepatic P450 enzyme activities in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effect of herbal teas on hepatic drug metabolizing enzymes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effects of green tea extract administration on the pharmacokinetics of clozapine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effects of repeated green tea catechin administration on human cytochrome P450 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Development of the proteasome inhibitor Velcade (Bortezomib).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Different cytotoxic and clastogenic effects of epigallocatechin gallate in various cell-culture media due to variable rates of its oxidation in the culture medium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

From orbital hybridization to chemotherapeutics neutralization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Therapeutic use of tea derivatives: all that glitters is not gold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Possible controversy over dietary polyphenols: benefits vs risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

A detailed examination of boronic acid–diol complexation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000644

Analysis of (-)-epigallocatechin gallate in human serum obtained after ingesting green tea

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB.60.2066

Identifiers

DOI

10.1002/MNFR.201000644

1 reference

24 August 2017

1 reference